Is GPR119 agonism an appropriate treatment modality for the safe amelioration of metabolic diseases?
Download
Download
Download
Full text for this resource is not available from the Research Repository.
Export
Cornall, Lauren, Mathai, Michael 
ORCID: https://orcid.org/0000-0001-8783-2122, Hryciw, Deanne H ORCID: https://orcid.org/0000-0003-1697-8890 and McAinch, Andrew ORCID: https://orcid.org/0000-0002-8762-4865
(2013)
Is GPR119 agonism an appropriate treatment modality for the safe amelioration of metabolic diseases?
Expert Opinion on Investigational Drugs, 22 (4).
pp. 487-498.
ISSN 1354-3784 (print) 1744-7658 (online)
Dimensions Badge
Altmetric Badge
| Item type | Article |
| URI | https://vu-9.eprints-hosting.org/id/eprint/21973 |
| DOI | 10.1517/13543784.2013.775245 |
| Subjects | Historical > Faculty/School/Research Centre/Department > School of Biomedical and Health Sciences Historical > FOR Classification > 1101 Medical Biochemistry and Metabolomics Historical > FOR Classification > 1103 Clinical Sciences |
| Keywords | GPR119, insulin, type 2 diabetes mellitus, metabolic disease, drug therapy, skeletal muscle, metabolism |
| Citations in Scopus | 19 - View on Scopus |
| Download/View statistics | View download statistics for this item |
CORE (COnnecting REpositories)